Wellosophy® Corporation Announces Receipt of its CE Mark

Clearwater, FL, February 10, 2017: Wellosophy® Corporation is a privately-held, US-based biotechnology company developing novel therapies that safely promote weight loss in overweight and obese patients. The Company, in cooperation with Eladiet S.A., its European partner (Barcelona, Spain: a CE-certified, cGMP maker of Nutraceuticals and Medical Devices), today announced the receipt of its CE Mark authorizing the sale of SWELL® – marketed as a Class IIa Medical Device under the tradename HydroSlim® in all 27-member European Union countries.